Ocugen

$康希诺(SH688185)$ $康希诺生物(06185)$ 康希诺合作研发的OCU410ST，获批进入2/3期临床试验。Ocugen宣布FDA已批准OCU410ST治疗Stargardt病的2/3期临床试验。OCU410ST 是一种AAV修饰基因治疗候选药物，正在开发用于治疗所有 Stargardt 病（ABCA4相关视网膜病变）。
FDA 此前已授予 OCU410ST 儿...

6 月 23 日，Carisma Therapeutics 和 Ocugen 的全资子公司 OrthoCellix 联合宣布，双方已达成反向合并协议，将以全股票交易的方式合并两家公司，旨在创建一家更大规模的、在纳斯达克上市的、处于临床后期的再生细胞治疗公司。
两家企业合并后的公司将专注于开发 OrthoCellix 的 NeoCart:regis...

$康希诺(SH688185)$ $康希诺生物(06185)$ 康希诺和Ocugen合作的针对 Stargardt 疾病，AAV基因修饰疗法OCU410ST，临床试验进展迅速，计划在未来几周内启动OCU410ST的2/3期关键性确证试验，目标是在2027年提交BLA申请。
Ocugen，5月27日宣布，FDA已授予OCU410ST，罕见儿科疾病指定(RPDD)，用于治...

$Ocugen(OCGN)$ 8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001104659-25-056875  Act: 34  Size: 221 KB 网页链接

$Ocugen(OCGN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001372299-25-000004  Act: 34  Size: 3 MB 网页链接

$Ocugen(OCGN)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-004921  Act: 33  Size: 4 KB 网页链接

$Ocugen(OCGN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001062993-25-011269  Size: 6 KB 网页链接

$Ocugen(OCGN)$ 8-K Current report, item 8.01 Accession Number: 0001104659-25-072197  Act: 34  Size: 186 KB 网页链接

$Ocugen(OCGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-25-072992  Act: 34  Size: 3 MB 网页链接

$Ocugen(OCGN)$ 3/A [Amend] Initial statement of beneficial ownership of securities Accession Number: 0001062993-25-011543  Size: 8 KB 网页链接

$Ocugen(OCGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-25-011275  Size: 5 KB 网页链接

$Ocugen(OCGN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-25-075953  Act: 33  Size: 470 KB 网页链接

$Ocugen(OCGN)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0002052113-25-003100  Act: 34  Size: 10 KB 网页链接

$Ocugen(OCGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-25-011273  Size: 5 KB 网页链接

$Ocugen(OCGN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001062993-25-011270  Size: 6 KB 网页链接

$Ocugen(OCGN)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-004194  Act: 33  Size: 5 KB 网页链接

$Ocugen(OCGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-25-037310  Act: 34  Size: 6 MB 网页链接

$Ocugen(OCGN)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001104659-25-061435  Act: 34  Size: 1 MB 网页链接

$Ocugen(OCGN)$ 8-K Current report, item 3.01 Accession Number: 0001104659-25-064695  Act: 34  Size: 188 KB 网页链接

$Ocugen(OCGN)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001104659-25-075956  Act: 34  Size: 757 KB 网页链接